Efficacy and Safety of Macitentan in Patients with Portopulmonary Hypertension: The Randomized, Placebo Controlled Portico Trial

被引：0

作者：

Krowka, Michael J. ^{[1
]}

Cottreel, Emmanuelle ^{[2
]}

De Groote, Pascal ^{[3
]}

Hoeper, Marius M. ^{[4
,5
]}

Kim, Nick ^{[6
]}

Martin, Nicolas ^{[2
]}

Savale, Laurent ^{[7
]}

Sitbon, Olivier ^{[7
]}

Bosch, Jaime ^{[8
,9
]}

机构：

[1] Mayo Clin Rochester, Rochester, MN USA

[2] Actel Pharmaceut Ltd, Allschwil, Switzerland

[3] CHRU Lille, Inst Pasteur Lille, Serv Cardiol, Inst Coeur Poumon,Inserm,U1167, Lille, France

[4] Hannover Med Sch, Hannover, Germany

[5] German Ctr Lung Res, Hannover, Germany

[6] Univ Calif San Diego, San Diego, CA 92103 USA

[7] Univ Paris Saclay, Univ Paris Sud, Hop Bicetre, Aphp,Inserm,Umr S999, Le Kremlin Bicetre, France

[8] Univ Barcelona, Hosp Clin Idibaps, Barcelona, Spain

[9] Univ Barcelona, Ciberehd, Barcelona, Spain

来源：

HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

111

引用

页码：70A / 71A

页数：2

共 50 条

[1] Late Breaking Abstract - Efficacy and safety of macitentan in portopulmonary hypertension: the PORTICO trial
Sitbon, Olivier
Bosch, Jaume
Cottreel, Emmanuelle
De Groote, Pascal
Hoeper, Marius M.
Krowka, Michael
Martin, Nicolas
Savale, Laurent
Kim, Nick
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[2] Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial
Sitbon, Olivier
Bosch, Jaume
Cottreel, Emmanuelle
Csonka, Denes
de Groote, Pascal
Hoeper, Marius M.
Kim, Nick H.
Martin, Nicolas
Savale, Laurent
Krowka, Michael
LANCET RESPIRATORY MEDICINE, 2019, 7 (07): : 594 - 604
[3] PORTICO: First Randomized Controlled Trial of Vasomodulator Therapy in Portopulmonary Hypertension
Raevens, Sarah
Fallon, Michael B.
HEPATOLOGY, 2020, 71 (05) : 1870 - 1872
[4] PHARMACOKINETICS OF MACITENTAN IN PATIENTS WITH PORTOPULMONARY HYPERTENSION: FINDINGS FROM THE PORTICO SUB-STUDY
Church, C. A.
Bosch, J.
Cottreel, E.
Csonka, D.
Hoeper, M.
Krowka, M.
Martin, N.
Kim, N. H.
Sitbon, O.
THORAX, 2018, 73 : A105 - A105
[5] Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis
Krowka, Michael
Cottreel, Emmanuelle
Hoeper, Marius M.
Kim, Nick H.
Martin, Nicolas
Sitbon, Olivier
Bosch, Jaume
LIVER TRANSPLANTATION, 2020, 26 (07) : 935 - 940
[6] Placebo Effect and Efficacy of Nebivolol in Patients with Hypertension not Controlled with Lisinopril or Losartan: A Phase IV, Randomized, Placebo-Controlled Trial
Robert J. Weiss
Manfred Stapff
Yuhua Lin
American Journal of Cardiovascular Drugs, 2013, 13 : 129 - 140
[7] Placebo Effect and Efficacy of Nebivolol in Patients with Hypertension not Controlled with Lisinopril or Losartan: A Phase IV, Randomized, Placebo-Controlled Trial
Weiss, Robert J.
Stapff, Manfred
Lin, Yuhua
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2013, 13 (02) : 129 - 140
[8] Efficacy and safety of tadalafil in portopulmonary hypertension
Jevnikar, Mitja
Ebstein, Nathan
Jais, Xavier
Boucly, Athenais
Montani, David
Humbert, Marc
Sitbon, Olivier
Savale, Laurent
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[9] Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism A Randomized Placebo-Controlled Trial
Shigematsu, Takashi
Koiwa, Fumihiko
Isaka, Yoshitaka
Fukagawa, Masafumi
Hagita, Keiko
Watanabe, Yukihisa S.
Honda, Daisuke
Akizawa, Tadao
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (10): : 1300 - 1309
[10] Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis
Kivitz, A
Eisen, G
Zhao, WW
Bevirt, T
Recker, DP
JOURNAL OF FAMILY PRACTICE, 2002, 51 (06): : 530 - 537

← 1 2 3 4 5 →